ID

27583

Beschreibung

Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS); ODM derived from: https://clinicaltrials.gov/show/NCT00846118

Link

https://clinicaltrials.gov/show/NCT00846118

Stichworte

  1. 21.11.17 21.11.17 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

21. November 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Cardiovascular Disease NCT00846118

Eligibility Cardiovascular Disease NCT00846118

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients under hemodialysis
Beschreibung

Hemodialysis

Datentyp

boolean

Alias
UMLS CUI [1]
C0019004
patients with hypercholesterolemia as defined by any of following parameters:
Beschreibung

Hypercholesterolemia

Datentyp

boolean

Alias
UMLS CUI [1]
C0020443
ldl-c ≧ 100 mg / dl
Beschreibung

Low density lipoprotein cholesterol measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0202117
tc ≧ 180 mg / dl
Beschreibung

Serum total cholesterol measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C1445957
patients required cholesterol-lowering treatment by investigators.
Beschreibung

Anticholesteremic Agents Patient need for

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003277
UMLS CUI [1,2]
C0686904
patients aged 20-75 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
patients with written consent by their own volition after being provided sufficient explanation for the participation into this clinical trial
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients taking statins or fibrates
Beschreibung

Statins | Fibrates

Datentyp

boolean

Alias
UMLS CUI [1]
C0360714
UMLS CUI [2]
C1449704
patients enrolled to the other trials using contraindication drugs of pitavastatin
Beschreibung

Study Subject Participation Status | Medical contraindication pitavastatin

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C1101838
patients who had acute myocardial infarction within six months before the day of the agreement acquisition
Beschreibung

Myocardial Infarction

Datentyp

boolean

Alias
UMLS CUI [1]
C0027051
patients scheduled pci and cabg within six months after the day of the agreement acquisition
Beschreibung

Percutaneous Coronary Intervention Scheduled | Coronary Artery Bypass Surgery Scheduled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1532338
UMLS CUI [1,2]
C0205539
UMLS CUI [2,1]
C0010055
UMLS CUI [2,2]
C0205539
patients who had diagnosis or doubt of malignant tumor
Beschreibung

Malignant Neoplasms | Malignant Neoplasms Unlikely

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0750558
patients corresponded to "contraindications" of pitavastatin
Beschreibung

Medical contraindication pitavastatin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1101838
familial hypercholesterolemia patients
Beschreibung

Hypercholesterolemia, Familial

Datentyp

boolean

Alias
UMLS CUI [1]
C0020445
patients judged ineligible by investigators
Beschreibung

Patients Ineligible

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1512714

Ähnliche Modelle

Eligibility Cardiovascular Disease NCT00846118

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Hemodialysis
Item
patients under hemodialysis
boolean
C0019004 (UMLS CUI [1])
Hypercholesterolemia
Item
patients with hypercholesterolemia as defined by any of following parameters:
boolean
C0020443 (UMLS CUI [1])
Low density lipoprotein cholesterol measurement
Item
ldl-c ≧ 100 mg / dl
boolean
C0202117 (UMLS CUI [1])
Serum total cholesterol measurement
Item
tc ≧ 180 mg / dl
boolean
C1445957 (UMLS CUI [1])
Anticholesteremic Agents Patient need for
Item
patients required cholesterol-lowering treatment by investigators.
boolean
C0003277 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
Age
Item
patients aged 20-75 years
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
patients with written consent by their own volition after being provided sufficient explanation for the participation into this clinical trial
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Statins | Fibrates
Item
patients taking statins or fibrates
boolean
C0360714 (UMLS CUI [1])
C1449704 (UMLS CUI [2])
Study Subject Participation Status | Medical contraindication pitavastatin
Item
patients enrolled to the other trials using contraindication drugs of pitavastatin
boolean
C2348568 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C1101838 (UMLS CUI [2,2])
Myocardial Infarction
Item
patients who had acute myocardial infarction within six months before the day of the agreement acquisition
boolean
C0027051 (UMLS CUI [1])
Percutaneous Coronary Intervention Scheduled | Coronary Artery Bypass Surgery Scheduled
Item
patients scheduled pci and cabg within six months after the day of the agreement acquisition
boolean
C1532338 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
C0010055 (UMLS CUI [2,1])
C0205539 (UMLS CUI [2,2])
Malignant Neoplasms | Malignant Neoplasms Unlikely
Item
patients who had diagnosis or doubt of malignant tumor
boolean
C0006826 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0750558 (UMLS CUI [2,2])
Medical contraindication pitavastatin
Item
patients corresponded to "contraindications" of pitavastatin
boolean
C1301624 (UMLS CUI [1,1])
C1101838 (UMLS CUI [1,2])
Hypercholesterolemia, Familial
Item
familial hypercholesterolemia patients
boolean
C0020445 (UMLS CUI [1])
Patients Ineligible
Item
patients judged ineligible by investigators
boolean
C0030705 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video